- AU$86.59m
- AU$80.15m
- AU$29.57m
- 64
- 56
- 50
- 61
Annual balance sheet for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.6 | 0.066 | 3.85 | 1.03 | 7.67 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.364 | 0.253 | 0.936 | 1.52 | 3.53 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.51 | 0.407 | 6.04 | 5.59 | 17.1 |
| Net Property, Plant And Equipment | 0.138 | 0.043 | 0.085 | 0.824 | 3.37 |
| Net Intangible Assets | |||||
| Total Assets | 2.68 | 0.45 | 17.7 | 6.7 | 20.9 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.745 | 0.815 | 2.69 | 2.91 | 8.45 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.798 | 0.815 | 2.56 | 3.09 | 9.22 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.88 | -0.365 | 15.1 | 3.61 | 11.7 |
| Total Liabilities & Shareholders' Equity | 2.68 | 0.45 | 17.7 | 6.7 | 20.9 |
| Total Common Shares Outstanding |